Prism Medico And Pharmacy Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2025 ,inter alia, to consider and approve 1. The Unaudited ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Prism Medico and Pharmacy Ltd has informed the stock exchanges that its Board of Directors will meet on Thursday, 14 August 2025, at 1:30 PM at the registered office in Kala Amb, Himachal Pradesh. The main agenda is to consider and approve the Unaudited Standalone Financial Results along with the Limited Review Report for the quarter ended 30 June 2025, in line with SEBI LODR Regulation 33. Any other routine business matters will also be discussed. The intimation has been issued under SEBI Listing Regulations to keep investors informed ahead of the results announcement.
No direct impact on shareholders from this filing — it is a routine advance notice. Investors should watch for the actual Q1 FY26 results on or after 14 August 2025, which will reveal the company's revenue, profitability, and operational performance for the quarter.